1-20 of 161
natural sciences
Close
Sort by
Journal Articles

Onset of Regulatory B Cells Occurs at Initial Stage of B Cell Dysfunction in Multiple Myeloma

Zhongqing Zou, Tingting Guo, Jian Cui, Li Zhang, Ling Pan
Journal: Blood
Blood (2019) 134 (Supplement_1): 1780.
https://doi.org/10.1182/blood-2019-128703
Published: 2019
Journal Articles

Dynamic Analysis of Cytokine Profile for Cytokine Release Syndrome in Multiple Myeloma Patients after CAR-T Cell Therapy

Shuangshuang Yang, MD, Lijuan Chen, MD PhD, Jie Xu, MD PhD, Frank Xiao-Hu Fan, MD PhD, Sun Yan, PhD, Wen Wu, MD PhD, Yan Wang, MD, Jin Wang, MD PhD, Shiwei Jin, MD, Yuebo Zhou, Yuanfang Liu, MD PhD, Yan Zhuang, PhD, Wu Zhang, PhD, Jun-Min Li, Jian Hou, PhD MD, Jian-Yong Li, MD PhD, Zhu Chen, PhD, Jian-Qing Mi, MD PhD, Sai-Juan Chen, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5617.
https://doi.org/10.1182/blood-2019-131799
Published: 2019
Journal Articles

Hexokinase II Expression As a Prognosis Marker in Diffuse Large B-Cell Lymphoma (DLBCL) Pre- and Post- the Incorporation of Rituximab to Standard CHOP Chemotherapy

Juan J. Gu, MD PhD, Yizhen Liu, MD PhD, Jia Jin, Ling Yang, Zuguang Xia, Xiaojian Liu, Fangfang Lv, MD, Francisco J. Hernandez-Ilizaliturri, MD, Xiaonan Hong, Junning Cao, MD, Qunling Zhang, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5233.
https://doi.org/10.1182/blood-2019-128878
Published: 2019
Journal Articles

A Novel Hybrid Transplantation with Autologous Hematopoietic Stem Cells and Matched Unrelated Cord Blood Stem Cells Is Effecttive and Safe for Relapsed or Refractory Lymphoma: A Pilot Study

Yongqian Jia, PhD, Jian Li, MD, Huan Tao, Pu Kuang, MD PhD, Jie Ji, MD, Xinchuan Chen, MD, Zhigang Liu, MD, Tian Dong, MD PhD, Jianjun Li, Fang Liu, MD PhD, Zhongping Lu, Ting Liu, MD, Ting Niu, MD PhD, Li Zhang, Fan Liu, Sha Zhao, Guochao Xu, Qiang Chen, Rong Tian, Jianchun Lu, Yamei Leng, Qiuhui Wu, Xu Xu, Yingli Wang
Journal: Blood
Blood (2019) 134 (Supplement_1): 5713.
https://doi.org/10.1182/blood-2019-129459
Published: 2019
Journal Articles

Updated Phase 1 Results of a First-in-Human Open-Label Study of Lcar-B38M, a Structurally Differentiated Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting B-Cell Maturation Antigen (Bcma)

Lijuan Chen, MD PhD, Jie Xu, MD PhD, Weijun Fu, Sr., MD PhD, Shiwei Jin, MD, Shuangshuang Yang, MD, Sun Yan, PhD, Wen Wu, MD PhD, Yuanfang Liu, MD PhD, Wu Zhang, PhD, Xiangqin Weng, Yan Wang, MD, Jin WANG, MD PhD, Xiaoyi Ding, Biao Li, Jiang Zhu, MD, Zhu Chen, PhD, Frank Xiao-Hu Fan, MD PhD, Jianyong Li, MD PhD, Jian Hou, PhD MD, Sai-Juan Chen, PhD, Jian-Qing Mi, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1858.
https://doi.org/10.1182/blood-2019-130008
Published: 2019
Journal Articles

Adoptive T-Cell Therapy with TCL1-Specific TCR for B-Cell Lymphomas

Jinsheng Weng, MD PhD, Kelsey Moriarty, BD, Yong Pan, Man Chun John MA, PhD, Rohit Mathur, PhD, Zheng Zhang, Hiroki Torikai, MD, Sourindra N Maiti, Fuliang Chu, PhD, Xiaoyun Cheng, Swathi Karri, Deepshika Medapalli, Laurence J N Cooper, MD PhD, R. Eric Davis, MD, Sattva S. Neelapu, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3488.
https://doi.org/10.1182/blood-2018-99-115424
Published: 2018
Journal Articles

Effect of Metabolic Reprogramming on the Biological Activity of Acute Myeloid Leukemia Cells

Tongyuan Liu, MD, Dengju Li, MD, Jianfeng Zhou, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5227.
https://doi.org/10.1182/blood-2018-99-115654
Published: 2018
Journal Articles

Development and Evaluation of CART Targeting Bcma with Humanized Alpaca-Derived Single-Domain Antibody As Antigen Recognition Domain

Lu Han, MS, Quanli Gao, MD, Keshu Zhou, MD, Qingsong Yin, PhD, Baijun Fang, MD, Jian Zhou, MD PhD, Xinghu Zhu, MD, Delong Liu, MD PhD, Jishuai Zhang, PhD, Haoyue Du, Hongjian Li, MS, Yongping Song, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1976.
https://doi.org/10.1182/blood-2018-99-114980
Published: 2018
Journal Articles

Effects of Overexpressed P2X7 on Leukemia Progression in Mouse Acute Myeloid Leukemia Model

Wenli Feng, PhD, Xiao Yang, PhD, Rong Wang, PhD, Feifei Yang, PhD, Hao Wang, PhD candidate, Xiaoli Liu, PhD candidate, Lina Wang, PhD, Guoguang Zheng, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5141.
https://doi.org/10.1182/blood-2018-99-110896
Published: 2018
Journal Articles

Multidimensional Study on the Prognostic Factors of Acute Myeloid Leukemia Patients with FLT3-ITD mutations Based on the Next-Generation Sequencing Platform

Yi Zhang, MDcal Master, Bide Zhao, Yungui Wang, PhD, Dongmei Wang, Hanzhang Pan, Chengcheng Wang, Feng Lou, Shanbo Cao, Jie Jin, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5281.
https://doi.org/10.1182/blood-2018-99-116178
Published: 2018
Journal Articles

AC0010, a Novel BTK Inhibitor, Exerts Anti-Leukemia Effects and Synergizes the Efficiency of Homoharringtonine in AML

Jie Jin, MD PhD, Shujuan Huang
Journal: Blood
Blood (2018) 132 (Supplement 1): 5153.
https://doi.org/10.1182/blood-2018-99-114350
Published: 2018
Journal Articles

High PARP-1 expression Predicts Poor Survival in Acute Myeloid Leukemia and PARP-1 Inhibitor and SAHA-Bendamustine Hybrid Inhibitor Combination Treatment Synergistically Enhances Anti-Tumor Effects

Xia Li, Chenying Li, Jingrui Jin, Jinghan Wang, Jie Jin, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5252.
https://doi.org/10.1182/blood-2018-99-114344
Published: 2018
Journal Articles

Deubiquitinase OTUD7B Is Potential Prognostic Biomarker in Diffuse Large B-Cell Lymphoma

Qunling Zhang, MD PhD, Juan Gu, MD PhD, Kai Xue, MD, Zuguang Xia, Cory Mavis, BSc, MSc, Francisco J. Hernandez-Ilizaliturri, MD, Ye Guo, Xiaonan Hong, Junning Cao, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4239.
https://doi.org/10.1182/blood-2018-99-118872
Published: 2018
Journal Articles

Expansion of Peripheral Extra-Follicular Helper T Cells in Patients with Chronic Graft-Versus-Host Disease

Hua Jin, Kaibo Yang, Haiyan Zhang, Zhiping Fan, Fen Huang, Yanyan Chai, Li Xuan, Yanqiu Chen, Qifa Liu, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4583.
https://doi.org/10.1182/blood-2018-99-113211
Published: 2018
Journal Articles

Downregulation of Mir-142 Promotes Leukemia Growth in Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL): A Possible Novel Therapeutic Target?

Huafeng Wang, Bin Zhang, PhD, Wei-Le Wang, BS, Dandan Zhao, MD, Ling Li, PhD, Herman Wu, BS, Le Xuan Truong Nguyen, PhD, Weixu Meng, MD PhD, Tinisha McDonald, MS, Flavia Pichiorri, PhD, Ya-Huei Kuo, PhD, Jianjun Chen, PhD, Nadia Carlesso, MD PhD, Ibrahim Aldoss, MD, Vinod A. Pullarkat, MD, Monzr Al Malki, MD, Anthony S. Stein, MD, Mark Boldin, MD PhD, Jie Jin, MD PhD, Guido Marcucci
Journal: Blood
Blood (2018) 132 (Supplement 1): 1338.
https://doi.org/10.1182/blood-2018-99-119599
Published: 2018
Journal Articles

Clinical Characteristics and Outcomes of 82 Patients with Mixed-Phenotype Acute Leukemia

Yan chun Yang, Ya Gao, MD, Ying Xu, Yintian Zhang, Dongmao Zhu, Zhiping Fan, Qifa Liu, MD, Baohong Ping
Journal: Blood
Blood (2018) 132 (Supplement 1): 1124.
https://doi.org/10.1182/blood-2018-99-114348
Published: 2018
Journal Articles

FPN1, Targeted By Mir-17-5p, Regulates Cellular Iron Homeostasis Via activating Nrf2/Mir-17-5p/FPN1 Axis in Preclinical Model of Multiple Myeloma

Yuanyuan Kong, Shuaikang Chang, Liangning Hu, Gege Chen, Yi Tao, Yingcong Wang, Dandan Yu, Kang Lu, Yongsheng Xie, Wenxuan Bu, Jumei Shi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5616.
https://doi.org/10.1182/blood-2018-99-112230
Published: 2018
Journal Articles

Rafoxanide, an Organohalogen Drug, Triggers Apoptosis and Cell Cycle Arrest in Multiple Myeloma By Enhancing DNA Damage Responses and Suppressing the p38 MAPK Pathway

Jumei Shi, Wenqin Xiao, Zhijian Xu, Shuaikang Chang, Lu Gao, Yi Tao, Yingcong Wang, Xiaosong Wu, Weiliang Zhu
Journal: Blood
Blood (2018) 132 (Supplement 1): 5628.
https://doi.org/10.1182/blood-2018-99-113782
Published: 2018
Journal Articles

Immunoregulatory Properties of Apoptotic Human Amniontic Mesenchymal Stromal Cells

Ying Xu, Ya Gao, MD, Yan chun Yang, Dongmao Zhu, Yintian Zhang, Ke Zhao, Yu Zhang, Qifa Liu, MD, Haitao Sun, Baohong Ping
Journal: Blood
Blood (2018) 132 (Supplement 1): 5678.
https://doi.org/10.1182/blood-2018-99-112585
Published: 2018
Journal Articles

Overall Survival (OS) Benefit of Oral Ixazomib in Combination with Lenalidomide and Dexamethasone (IRd) Vs Lenalidomide and Dexamethasone (Rd) in Asian Patients (pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): Pooled-Analysis from the Tourmaline-MM1 and the China Continuation Studies

Weijun Fu, MD PhD, Jin Lu, Jie Jin, MD PhD, Yan Xu, MD, Depei Wu, Dao-bin Zhou, MD, Xiaoyan Ke, Xin Du, MD PhD, Xiequn Chen, MD PhD, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS, Kihyun Kim, MD PhD, Junmin Li, MD PhD, Jae Hoon Lee, MD PhD, Jing Liu, PhD, Yeow Tee Goh, MBBS, MD, Kwang-Wei Wu, MD, Hui Wang, MD, Guohui Liu, PhD, Tomas Skacel, MD PhD, Hui Wan, MD PhD, Deborah Berg, RN, MSN
Journal: Blood
Blood (2018) 132 (Supplement 1): 5637.
https://doi.org/10.1182/blood-2018-99-116844
Published: 2018